399 related articles for article (PubMed ID: 16740856)
1. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
Berhe T; Postellon D; Wilson B; Stone R
Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
[TBL] [Abstract][Full Text] [Related]
3. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
5. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
6. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
7. Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study.
Giménez M; Lara M; Conget I
Diabetes Technol Ther; 2010 Jul; 12(7):517-21. PubMed ID: 20597825
[TBL] [Abstract][Full Text] [Related]
8. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
10. [Continuous subcutaneous insulin infusion].
Balsa AM; Neves C; Alves M; Pereira M; Carvalho D; Medina JL
Acta Med Port; 2011 Dec; 24 Suppl 2():147-56. PubMed ID: 22849898
[TBL] [Abstract][Full Text] [Related]
11. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
Pańkowska E; Szypowska A; Lipka M; Skórka A
Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of insulin-dependent diabetes mellitus by insulin pump in children under 7 years of age].
Joseph MG; Ginies JL; Chomienne F; Limal JM
Arch Fr Pediatr; 1992; 49(6):505-10. PubMed ID: 1449351
[TBL] [Abstract][Full Text] [Related]
15. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
Patton SR; Dolan LM; Henry R; Powers SW
Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
[TBL] [Abstract][Full Text] [Related]
16. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
[TBL] [Abstract][Full Text] [Related]
17. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
Hoogma RP; Schumicki D
Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
[TBL] [Abstract][Full Text] [Related]
18. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
19. Metabolic control with insulin pump therapy: the Waikato experience.
Reda E; Von Reitzenstein A; Dunn P
N Z Med J; 2007 Jan; 120(1248):U2401. PubMed ID: 17277817
[TBL] [Abstract][Full Text] [Related]
20. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy.
Lapolla A; Dalfrà MG; Masin M; Bruttomesso D; Piva I; Crepaldi C; Tortul C; Dalla Barba B; Fedele D
Acta Diabetol; 2003 Sep; 40(3):143-9. PubMed ID: 14605971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
